David Noga
Psychiatry · Akron, OHNPI 1073018974
Payments from drug & device makers
Across 205 payments — averaging $17.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$753
- Lundbeck LLC$553
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$479
- Teva Pharmaceuticals USA, Inc.$346
- Alkermes, Inc.$345
- Otsuka America Pharmaceutical, Inc.$323
- plus $717 from 6 others
What the payments were for
- Food & beverage$3,45698%
- Education$592%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 44 | $753 |
| Lundbeck LLC | 32 | $553 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 35 | $479 |
| Teva Pharmaceuticals USA, Inc. | 21 | $346 |
| Alkermes, Inc. | 19 | $345 |
| Otsuka America Pharmaceutical, Inc. | 18 | $323 |
| AbbVie | 12 | $242 |
| Neurocrine Biosciences, Inc. | 12 | $208 |
| Indivior Inc. | 9 | $186 |
| E.r. Squibb & Sons, L.L.C. | 1 | $37 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Braeburn Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Austedo XR$138
- CAPLYTA$123
How this compares
$3,516 in reported general payments places this provider in the 85th percentile of 1,119 psychiatry providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 354 | $950,309 |
| Invega TrinzaPaliperidone Palmitate | 51 | $394,774 |
| IngrezzaValbenazine Tosylate | 45 | $341,941 |
| AristadaAripiprazole Lauroxil | 14 | $36,493 |
| Abilify MaintenaAripiprazole | 13 | $33,808 |
| Paliperidone ErPaliperidone | 133 | $18,049 |
| Seroquel XrQuetiapine Fumarate | 26 | $17,799 |
| Risperidone ErRisperidone Microspheres | 15 | $14,725 |
| TrintellixVortioxetine Hydrobromide | 27 | $14,010 |
| Clozapine | 255 | $13,496 |
| Olanzapine | 445 | $9,699 |
| Divalproex Sodium ErDivalproex Sodium | 255 | $8,918 |
| Aripiprazole | 194 | $4,792 |
| Varenicline Tartrate | 13 | $4,123 |
| Chlorpromazine Hcl | 15 | $2,600 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna, Invega Trinza | $753 | $1,345,083405 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $208 | $341,94145 claims |
| Alkermes, Inc.Aristada | $345 | $36,49314 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $323 | $33,80813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,119 psychiatry providers in Ohio.
Other psychiatry in Akron
- Shishuka MalhotraCanton$15M
- Henry NasrallahCincinnati$3.8M
- Otto DuenoDayton$3.1M
- Diab AlmhanaAvon Lake$2.7M
- Mohamed Abdel AzizWest Chester$2.6M
- Fred RomeoColumbus$2.3M
- Mark WoyshvilleMiddleburg Heights$2.2M
- Amita PatelDayton$2.1M
- Caleb AdlerCincinnati$2M
- Richard SandersDayton$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.